In the latest PDA Letter “On the Issue” video,
recently retired from Amgen, discusses the
issues currently impacting the pharmaceutical supply chain,
including new serialization requirements from the EU and the
continued threat from counterfeit pharmaceuticals. He draws
from his years of experience to discuss what industry can do to
respond to these supply chain challenges.